What is the projected market valuation for the South Korea biosimilar contract-manufacturing market by 2035?

The projected market valuation is $778.53 Million by 2035. Read More

What was the market valuation for the South Korea biosimilar contract-manufacturing market in 2024?

The market valuation was $115.93 Million in 2024. Read More

Which companies are considered key players in the South Korea biosimilar contract-manufacturing market?

Key players include Samsung Biologics, Lonza Group, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies, Wuxi Biologics, Roche, Amgen, and Sandoz. Read More

What are the two main product segments in the South Korea biosimilar contract-manufacturing market?

The two main product segments are Recombinant Non-glycosylated Proteins and Recombinant Glycosylated Proteins. Read More

What was the valuation for the Recombinant Glycosylated Proteins segment in 2024?

The valuation for the Recombinant Glycosylated Proteins segment was $75.93 Million in 2024. Read More

What production technologies are utilized in the South Korea biosimilar contract-manufacturing market?

The production technologies include Mammalian and Non-Mammalian systems. Read More

What was the valuation for the Mammalian production technology segment in 2024?

The valuation for the Mammalian production technology segment was $69.56 Million in 2024. Read More

Which application segment had the highest valuation in 2024 within the South Korea biosimilar contract-manufacturing market?

The Chronic & Autoimmune Disorders application segment had the highest valuation at $29.0 Million in 2024. Read More

What is the projected growth for the Chronic & Autoimmune Disorders application segment by 2035?

The projected growth for the Chronic & Autoimmune Disorders application segment is expected to reach $205.78 Million by 2035. Read More

South Korea Biosimilar Contract Manufacturing Market

Q: What is the expected CAGR for the South Korea biosimilar contract-manufacturing market during the forecast period 2025 - 2035?

The expected CAGR is 18.9% during the forecast period 2025 - 2035. Read More

ID: MRFR/MED/50108-HCR

200 Pages

Nidhi Mandole

Last Updated: February 06, 2026

South Korea Biosimilar Contract Manufacturing Market Research Report: Size, Share, Trend Analysis By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Production Technology (Mammalian, Non-Mammalian) and By Applications (Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic & Autoimmune Disorders, Rheumatoid Arthritis, Others) - Growth Outlook & Industry Forecast 2025 To 2035

South Korea Biosimilar Contract Manufacturing Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Security, Access Control and Robotics, BY Product (USD Million)
  1. 4.1.1 Recombinant Non-glycosylated Proteins
  2. 4.1.2 Recombinant Glycosylated Proteins
2. 4.2 Security, Access Control and Robotics, BY Production Technology (USD Million)
  1. 4.2.1 Mammalian
  2. 4.2.2 Non-Mammalian
3. 4.3 Security, Access Control and Robotics, BY Application (USD Million)
  1. 4.3.1 Oncology
  2. 4.3.2 Blood Disorders
  3. 4.3.3 Growth Hormonal Deficiency
  4. 4.3.4 Chronic & Autoimmune Disorders
  5. 4.3.5 Rheumatoid Arthritis
  6. 4.3.6 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Samsung Biologics (KR)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Lonza Group (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boehringer Ingelheim (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Fujifilm Diosynth Biotechnologies (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Wuxi Biologics (CN)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Roche (CH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Amgen (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sandoz (CH)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY PRODUCT
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
5. 6.5 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
8. 6.8 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
9. 6.9 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
10. 6.10 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
11. 6.11 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCT, 2024 (% SHARE)
12. 6.12 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCT, 2024 TO 2035 (USD Million)
13. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCTION TECHNOLOGY, 2024 (% SHARE)
14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCTION TECHNOLOGY, 2024 TO 2035 (USD Million)
15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATION, 2024 (% SHARE)
16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATION, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Security, Access Control and Robotics Market Segmentation

Security, Access Control and Robotics By Product (USD Million, 2025-2035)

Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins

Security, Access Control and Robotics By Production Technology (USD Million, 2025-2035)

Mammalian
Non-Mammalian

Security, Access Control and Robotics By Application (USD Million, 2025-2035)

Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic & Autoimmune Disorders
Rheumatoid Arthritis
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”